This extraordinary virtual meeting for the Strategic Advisory Group of Experts on Immunization (SAGE) was held on Tuesday 05 January 2021 to propose recommendations to WHO on the use of COVID-19 vaccine(s).
Interim WHO recommendations
This interim guidance has been developed based on the advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) at its 5 January 2021 extraordinary meeting.
Meeting materials
Please find related materials for the meeting, including a final agenda, list of participants, declaration of interests, background materials and presentations made during the meeting, below.
Background Materials
Presentations
Introduction, session objective setting, update on regulatory decisions and overview of Working Group deliverables
H. NOHYNEK. pdf, 4.1Mb
H. NOHYNEK. pdf, 4.1Mb
Vaccine safety and efficacy data emerging from
Pfizer-BioNTech mRNA COVID-19 vaccine clinical trials
(phase 1-3 trial results). Risk management plans and
other implementation considerations
Condensed presentation from Pfizer. pdf, 1.5Mb
Condensed presentation from Pfizer. pdf, 1.5Mb
Safety monitoring
S. Pal. pdf, 1Mb
S. Pal. pdf, 1Mb
Assessment of Evidence (SAGE working group)
SAGE Working Group. pdf, 3.6Mb
SAGE Working Group. pdf, 3.6Mb